接受保乳治疗的乳腺导管原位癌患者初次活检标本的病理特征与再次切除时残留导管内癌的相关性。

Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy.

作者信息

Goldstein N S, Kestin L, Vicini F

机构信息

Department of Anatomic Pathology, William Beaumont Hospital, Royal Oak, MI 48073-6769, USA.

出版信息

Am J Surg Pathol. 1999 Nov;23(11):1340-8. doi: 10.1097/00000478-199911000-00004.

Abstract

The histologic criteria for determining which patients require a reexcision after an initial excisional biopsy for ductal carcinoma in situ (DCIS) of the breast are poorly defined. The authors examined the initial biopsy specimens of 98 patients with inked margins and determined the amount of DCIS on reexcision to help clarify which histologic criteria are useful in judging the need for reexcision. Features in initial biopsy specimens that were associated with an increasing number of slides with DCIS on reexcision were an increasing number of slides with DCIS, an increasing number of DCIS ducts or terminal duct lobular units (TDLUs) with "cancerization" of lobules (COL) within 0.42 cm of the inked margin, and multifocal positive margins. In patients with negative (>0.2 cm) initial biopsy specimen margins, an increasing number of DCIS ducts or TDLUs with COL near the initial biopsy specimen margin were also associated significantly with an increasing number of slides with DCIS on reexcision. Six or more slides with DCIS or 11 or more DCIS ducts or TDLUs with COL within 0.42 cm of the inked margin in the initial biopsy specimens were associated with 6 or more slides with DCIS on reexcision. These results suggest that the amount of DCIS in initial biopsy specimens and the amount of DCIS near the margin are associated with the quantity of DCIS remaining in the breast after an initial excisional biopsy. Pathologists can use these factors when assisting clinicians in evaluating the need for a reexcision.

摘要

用于确定哪些患者在首次切除活检后需要对乳腺导管原位癌(DCIS)进行再次切除的组织学标准尚不明确。作者检查了98例切缘标记的患者的初次活检标本,并确定再次切除时DCIS的数量,以帮助明确哪些组织学标准有助于判断再次切除的必要性。初次活检标本中与再次切除时含有DCIS的切片数量增加相关的特征包括:含有DCIS的切片数量增加、在距离标记切缘0.42 cm范围内含有小叶“癌变”(COL)的DCIS导管或终末导管小叶单位(TDLU)数量增加以及多灶性阳性切缘。在初次活检标本切缘阴性(>0.2 cm)的患者中,初次活检标本切缘附近含有COL的DCIS导管或TDLU数量增加也与再次切除时含有DCIS的切片数量增加显著相关。初次活检标本中在距离标记切缘0.42 cm范围内有6个或更多含有DCIS的切片或11个或更多含有COL的DCIS导管或TDLU与再次切除时6个或更多含有DCIS的切片相关。这些结果表明,初次活检标本中DCIS的数量以及切缘附近DCIS的数量与初次切除活检后乳腺中残留的DCIS数量相关。病理学家在协助临床医生评估再次切除的必要性时可以使用这些因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索